Huaxi biological diving fell by more than 11%

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

HKEX Announces Commitment to Carbon Neutrality by 2024

Financial regulators are placing increasing emphasis on sustainable development, and multiple market identities will make more significant contributions.

SAC Releases CSR Report of Securities Firms 2022

As an important participant in the capital market, securities firms should give full play to their professional strengths and specialties, contributing to China's high-quality development.

EqualOcean Founding Partner Yuanpu Huang: Long China, a New Playbook in New Era

On November 10, Yuanpu Huang, the Founding Partner EqualOcean, was invited by China Creation Ventures (CCV) to give a speech on Long China, a New Playbook in New Era in English. He believes that Go Global will be the opportunity of the times for Chinese companies. Here we present the edited transcript.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.